US could learn from Cuban AIDS policy
Contaminated needles and the spread of HIV in Africa
HIV regulatory protein Tat
When should antiretroviral therapy be started for HIV infection? Interpreting the evidence from observational studies
Dynamics of HIV viremia and antibody seroconversion in plasma donors
Persistent immune activation in HIV-1 infection is associated with progression to AIDS
Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors
Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration
Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy
Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy
High levels of adherence do not prevent accumulation of HIV drug resistance mutations
Efficacy of indinavir–ritonavir-based regimens in HIV-1-infected patients with prior protease inhibitor failures
Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda
Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users
Impact of HIV infection on invasive cervical cancer in Kenyan women
A survey of sexual risk behavior for HIV infection in Nakhonsawan, Thailand, 2001
Intrafamilial transmission of HIV-1 infection from individuals with unrecognized HIV-1 infection
Plasma levels of B-lymphocyte stimulator increase with HIV disease progression
Altered lymphocyte heat shock protein 70 expression in patients with HIV disease
Drug-induced aminotransferase alterations during antiretroviral HIV post-exposure prophylaxis
Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherence
Stavudine or indinavir-containing regimens are associated with an increased risk of diabetes mellitus in HIV-infected individuals
Highly active antiretroviral therapy in resource-poor settings
Definition of loss of virological response in trials of antiretroviral drugs
Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma
Ability to generate synthetic peptides that immunologicaly mimic HIV-1 tat regulatory protein
HIV (AIDS), maternal malaria and prolactin
Urinary pH in HIV-infected adults in Ivory Coast and in France
Antiretroviral therapy in a primary care clinic in rural South Africa
Intensive chemotherapy with rituximab is safe and effective in AIDS non-Hodgkin's lymphoma
Disseminating knowledge about AIDS through the Indian family planning programme
Women have a greater immunological response to effective virological HIV-1 therapy
Response to ‘High-risk sexual behaviour increases among London gay men between 1998 and 2001
Authors’ response to letter from I.G. Stolte and N.H.T.M. Dukers concerning the paper ‘High-risk sexual behaviour increases among London gay men between 1998 and 2001